5C6T image
Entry Detail
PDB ID:
5C6T
Title:
Crystal structure of HCMV glycoprotein B in complex with 1G2 Fab
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2015-06-23
Release Date:
2015-09-23
Method Details:
Experimental Method:
Resolution:
3.60 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Envelope glycoprotein B
Chain IDs:A
Chain Length:636
Number of Molecules:1
Biological Source:Human cytomegalovirus
Polymer Type:polypeptide(L)
Description:1G2 Fab heavy chain
Chain IDs:B (auth: H)
Chain Length:233
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:1G2 Fab light chain
Chain IDs:C (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody.
Nat Commun 6 8176 8176 (2015)
PMID: 26365435 DOI: 10.1038/ncomms9176

Abstact

Human cytomegalovirus (HCMV) poses a significant threat to immunocompromised individuals and neonates infected in utero. Glycoprotein B (gB), the herpesvirus fusion protein, is a target for neutralizing antibodies and a vaccine candidate due to its indispensable role in infection. Here we show the crystal structure of the HCMV gB ectodomain bound to the Fab fragment of 1G2, a neutralizing human monoclonal antibody isolated from a seropositive subject. The gB/1G2 interaction is dominated by aromatic residues in the 1G2 heavy chain CDR3 protruding into a hydrophobic cleft in the gB antigenic domain 5 (AD-5). Structural analysis and comparison with HSV gB suggest the location of additional neutralizing antibody binding sites on HCMV gB. Finally, immunoprecipitation experiments reveal that 1G2 can bind to HCMV virion gB suggesting that its epitope is exposed and accessible on the virus surface. Our data will support the development of vaccines and therapeutic antibodies against HCMV infection.

Legend

Protein

Chemical

Disease

Primary Citation of related structures